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Original Article
Environmental disturbance confounds prenatal glucocorticoid
programming experiments in Wistar rats
D O’Regan1, C J Kenyon2, J R Seckl2 and M C Holmes2
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Unit, Centre for Cardiovascular Science, Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK
Corresponding author: D O’Regan. Email: d.oregan@imperial.ac.uk
Abstract
Low birth weight in humans is predictive of hypertension in adult life, and while the mechanisms underlying this link remain
unknown, fetal overexposure to glucocorticoids has been implicated. We have previously shown that prenatal dexamethasone
(DEX) exposure in the rat lowers birth weight and programmes adult hypertension. This current study aimed to unravel the
molecular nature of this hypertension. However, unknowingly, post hoc investigations revealed that our animals had been
subjected to environmental noise stresses from an adjacent construction site, which were sufficient to confound our prenatal
DEX-programming experiments. This perinatal stress successfully established low birth weight, hypercorticosteronaemia,
insulin resistance, hypertension and hypothalamic–pituitary–adrenal axis dysfunction in vehicle (VEH)-treated offspring, such
that the typical distinctions between both treatment groups were ameliorated. The lack of an additional effect on DEX-treated
offspring is suggestive of a maximal effect of perinatal stress and glucocorticoids, serving to prevent against the potentially
detrimental effects of sustained glucocorticoid hyper-exposure. Finally, this paper serves to inform researchers of the
potential detrimental effects of neighbouring construction sites to their experiments.
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As research institutions expand and respond to ever-
changing building and animal welfare regulations, they
are required to undergo either new construction and/or
renovation. However, such structural changes are associated
with a plethora of nuisances, such as noise and vibration,
with each disturbance being capable of powerfully stimulat-
ing the hypothalamic–pituitary–adrenal (HPA) axis.1 The
auditory system is permanently open – even during sleep.
Its rapid and overshooting excitations in response to noise
signals are subcortically connected, via the amygdala,
to the HPA axis, resulting in corticotrophin releasing
hormone and adrenocorticotrophic hormone release.2 Animal
experiments show noise-induced changes in the sensitivity
of glucocorticoid receptor (GR) by increase of heat-shock
proteins3 and ultrastructural changes of the adrenal
gland.4 Increased cortisol levels have been found in
humans when exposed to aircraft5 or road trafﬁc noise,6
even during sleep,7 implying these effects are mainly
without mental control. Of course, increased glucocorticoid
and sympathetic neural secretion is a perfect short-term
stress response, coordinating appropriate metabolic and
vascular changes, and thereby assisting the individual to
negotiate the stressor. However, over prolonged time
periods, such as persistent noise-induced stress responses,
can be gravely damaging to health.2,8
Numerous animal studies have documented the program-
ming effects of pre- and postnatal stress on offspring physi-
ology and behaviour, which are remarkably analogous
to those induced by fetal glucocorticoid overexposure.
Exposing pregnant dams to stressful stimuli results in
both maternal and fetal HPA activation.9,10 Moreover,
these offspring display an activated HPA axis till weaning,
as adults are more anxious and stress-responsive.10,11
These adverse behavioural effects are associated with
altered patterns of brain GR expression, as well as altera-
tions in the circadian rhythm of corticosterone secretion,11
consistent with HPA axis dysregulation. Similarly, prenatal
dexamethasone (DEX) treatment results in permanent life-
long hyperactivation of the HPA axis,12 also associated
with altered brain GR expression and increased
anxiety-related behaviour.13 The sympathetic nervous
system (SNS) further participates in stress responses, even
in fetal life,14 and prenatal exposure to various stressors
affects the development of sympathetic innervation and/or
its regulation.15 One study on the offspring of rats kept in
hypoxia during pregnancy showed altered development of
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sympathetic centres involved in blood pressure regulation,
which continued to adversely affect offspring blood
pressure throughout adulthood.16 In line with these obser-
vations, we found that prenatal DEX-treated offspring
display hypersensitive pressor responses to even the
mildest stressor (e.g. being weighed), and that the resulting
stress-induced hypertension is mediated by altered sym-
pathetic nerve responsivity.15 Postnatal manipulations,
such as handling newborn pups, also induce modiﬁed
stress responses, by reducing anxiety through altered HPA
feedback sensitivity and hippocampal GR expression.17
Here we report the phenotypes of offspring treated with
either vehicle (VEH) or DEX during the last week of ges-
tation, which were unintentionally further subjected to peri-
natal stress, as a result of adjacent construction work. The
facility in which our animals are housed was refurbished
during this time, and was further located next to a newly
constructed wing of a large district general hospital.
Materials and methods
Animals
Adult Wistar rats (200–250 g; Harlan, Bicester, UK, catalogue
number Hsd:W1), housed in open-top cages, were maintained
under conditions of controlled lighting (lights on 07:00 to
19:00) and temperature (228C), and allowed ad libitum access
to food (CRM(E) rat and mouse breeder and grower expanded
diet: 61.9% carbohydrate, 18.8% protein, 3.4% oil, 0.6% NaCl;
SDS, Wiltham, UK) and non-treated tap water. All exper-
iments were performed in accordance with the UK Animals
(Scientiﬁc Procedures) Act, 1986.
Prenatal treatments
Virgin female rats were housed with adult male rats.
Pregnancy was conﬁrmed by the presence of a vaginal
plug, checked every morning. Pregnant females were
housed singly and randomly assigned to one of two treatment
groups (n ¼ 9–10/group). DEX (100 mg/kg/day, dissolved in
4% ethanol–0.9% saline, 200 mg/mL; Sigma-Aldrich, Poole,
UK) was given subcutaneously during the ﬁnal week of ges-
tation (embryonic days 14–21 inclusive). A control group
received VEH injections during the same time period.
Litters
On the day of birth (postnatal day 1), litters were weighed,
sexed and culled to eight pups per litter, retaining equal
numbers of male and female pups where possible. Litters
were then left undisturbed until weaning (postnatal day
21), apart from routine weekly maintenance. After
weaning, male and female pups from each litter were
housed in single-sex groups of two to four and left undis-
turbed until the time of testing.
Blood sampling
Blood samples taken from the tail vein of conscious rats
wrapped in a folded tea towel on the investigator’s lap
took less than 2 min to complete after removal of the rat
from its home cage. Applying thumb and index ﬁnger
pressure to the proximal part of the tail, a scalpel blade
was used to make a nick incision in the distal part of the
tail vein to initiate blood ﬂow. The tail was subsequently
gently milked to ascertain the sample. Blood was collected
in Microvette tubes (Sarstedt, Leicester, UK) and stored on
ice until centrifugation at 48C. Subsequently, all the
plasma was stored at 2808C until assayed.
Plasma hormonal assays
Plasma corticosterone was analysed with the use of an
in-house speciﬁc radioimmunoassay as described pre-
viously18 and modiﬁed for microtitre plate scintillation
proximity assay (Amersham Pharmacia Biotech,
Buckinghamshire, UK). Inter- and intra-assay variations
were ,10%.
HPA axis activity
To assess circadian variation in plasma corticosterone con-
centrations, rats were handled daily for a minimum of
15 min by the same investigator for two weeks before exper-
iments. Initially they were allowed to roam freely on the
investigator’s lap while being stroked by the investigator,
before being habituated to being held in a folded tea
towel. Blood samples were taken at 08:00 and 20:00.
Oral glucose tolerance test
Offspring underwent an oral glucose tolerance test (OGTT)
at six months of age.19 Animals were fasted overnight, and
testing commenced between 08:30 and 09:00 the following
morning. An oral glucose load of 2 g/kg was given by
gavage, and blood samples were collected at 0, 30 and 120
min. Glucose was determined by the enzymatic (hexoki-
nase) method using a kit (Sigma, Poole, UK). Inter- and
intra-assay variations were ,2%. Insulin was measured by
enzyme-linked immunosorbent assay (Ultrasensitive Rat
Insulin ELISA kit; Crystal Chem, Chicago, IL, USA). Inter-
and intra-assay variations were ,10%.
Phosphoenolpyruvate carboxykinase enzyme activity
At weaning (postnatal day 21), fed animals were killed by
decapitation between 09:00 and 10:00, and livers were
removed immediately. Phosphoenolpyruvate carboxykinase
(PEPCK) activity was measured as previously described.20
Blood pressure measurement
Animals between two and three months of age were
handled daily and accustomed to the measurement
routine for one week before commencement of the exper-
iment. Systolic blood pressure was measured by either an
automated tail cuff-plethysmography method or carotid
cannulation as previously described.21,22
................................................................................................................................................
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Statistical analyses
All data are expressed as means+SEM. Data were com-
pared using one-way or multiple analysis of variance
(ANOVA) followed by a least signiﬁcant difference post
hoc multiple comparisons test or unpaired Student’s
t-tests, where appropriate. Values were considered signiﬁ-
cant when P, 0.05.
Results
Birth phenotype and catch-up growth
As expected, DEX administration throughout the ﬁnal week
of gestation resulted in a signiﬁcant decrease in birth
weight, i.e. VEH 5.9+ 0.05 g, DEX 5.4+ 0.05 g (n ¼ 67 for
both groups, P, 0.01 by Student’s t-test), representing a
mean 8.5% reduction in birth weight as a result of prenatal
DEX treatment. No differences in gestation length (VEH and
DEX; 22+ 0 days, n ¼ 8 per group) or litter size (VEH; 9+ 1
pups versus DEX; 8+ 1 pups, n ¼ 67 per group) were
noted. Figure 1 reveals that male and female offspring
from both treatment groups gained weight throughout the
course of their postnatal life. Contrary to previous studies,
DEX-treated offspring only exhibited catch-up growth
until approximately three months of age, thereafter it
ceased and they remained approximately 11% lighter than
controls for the remainder of their life; for example, at 210
days of age, mean body masses were 660+ 14 and 591+
12 g for VEH- and DEX-treated offspring (n ¼ 34 and 39,
respectively, P, 0.05 by Student’s t-test).
Systolic blood pressure
Although there was a trend for DEX-treated offspring to
display elevated systolic blood pressure when measured
by carotid cannulation, this did not reach statistical signiﬁ-
cance in the present cohort (Figure 2). Similarly, no effect
of prenatal treatment was revealed by tail-cuff plethysmo-
graphy at either two or three months of age (Figure 2).
However, systolic blood pressure did increase signiﬁcantly
between two and three months of age in both VEH (from
120+ 7 to 145+ 5 mmHg, P, 0.05, one-way ANOVA fol-
lowed by post hoc test) and DEX (from 128+ 2.5 to 146+
5.5 mmHg, P, 0.05, one-way ANOVA followed by post
hoc test) treated offspring.
Prenatal DEX, hepatic PEPCK activity and
glucose homeostasis
Contrary to previous studies, no difference was observed
between the prenatal treatment groups on hepatic PEPCK
activity (Figure 3a) at three months of age. This was
further associated with a lack of effect of prenatal DEX treat-
ment on either plasma glucose (Figure 3b) or insulin
(Figure 3c) during an OGTT, performed at six months
of age.
Plasma corticosterone concentrations
At three months of age, both male and female offspring of
both prenatal treatment groups displayed greatly elevated
increases in basal morning (08:00) plasma CORT
(Figure 4), compared with those levels normally observed
in our laboratory (Table 1).
Figure 1 Growth trajectory of offspring to seven months of age. (a) Growth
trajectory of male and female dexamethasone (DEX)- and vehicle
(VEH)-treated offspring. Data are presented as mean+SEM, n ¼ 34 (DEX)
and 39 (VEH). (b) Catch-up growth of DEX-treated rats: ratio of mean body
weights of DEX versus VEH-treated offspring over the same time period
Figure 2 Offspring systolic blood pressure at two and three months of age.
Systolic blood pressure of vehicle (VEH) and dexamethasone (DEX)-treated
male offspring at two and three months of age, measured by carotid cannula-
tion (average of 2 consecutive days; readings were taken within the first 10 min
after connection of the animal to the apparatus) or tail-cuff plethysmography
(average of measurements recorded on the last 3 days of 7 days consecutive
measurements). Data are presented as mean+SEM, n ¼ 4–6 per group for
carotid cannulation and n ¼ 10 per group for tail-cuff plethysmography,
one-way analysis of variance followed by post hoc test, P, 0.05
................................................................................................................................................
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Detection of environmental disturbance
As each characterizing experiment began to highlight the col-
lapse of our prenatal progamming model, we began an exten-
sive hunt of potential stressors. With no change to animal
chow, bedding, water supply or animal carers, we looked
to an adjacent construction site as the potential perinatal
stressor. During construction of the new hospital wing, corti-
costerone levels were assayed regularly in non-prenatally
manipulated rats. These animals were bred in-house, and
revealed persistent hypercorticosteronaemia during the con-
struction, e.g. 08:00 samples: 446.5+158 nmol/L (n ¼ 8) at
four weeks and 456.5+142 nmol/L (n ¼ 8) at six weeks
during building works.
Plasma corticosterone levels in VEH-treated male
offspring, and naı¨ve males after the cessation
of adjacent building construction
As demonstrated in Figure 5, VEH-treated offspring, aged
eight months revealed signiﬁcant reductions in their basal
corticosterone levels, though they still exceeded the upper
limit of the normal. Conversely, naı¨ve animals bought into
our research facility had corticosterone levels of 31.5+
6 nmol/L (n ¼ 8); values were lying well within the
normal basal range for our laboratory. Construction of the
neighbouring building was completed at this time of testing.
Comparison of offspring phenotypes pre-, during
and post-nearby construction
Characterization of this cohort revealed a phenotype
that differed substantially from previous and subsequent
cohorts of prenatally treated offspring. A summary of the
results highlighting the discrepancies between offspring
cohorts generated for this study, and those before and
after the cessation of building work, is outlined in Table 1.
Discussion
This paper recounts data acquired during a series of inves-
tigations intended to unravel the molecular mechanisms
underlying the hypertensive phenotype of the
DEX-programmed rat. Instead, it reveals how the physio-
logical proﬁle of a prenatal VEH- or DEX-treated animal is
confounded by perinatal stress, induced in this case by con-
struction noise. Furthermore, during this same time period
the animal facility was frequently but irregularly passed
by a plethora of construction lorries and machines accessing
the adjacent building site, which would have involved the
emission of infrasound.2 Such environmental disturbances
would have been clearly audible to our cohorts, as rodents
possess a hearing range that incorporates both ultra- and
subsonic frequencies. Moreover, prenatal DEX-treatment
programmes greater cochlear sensitivity to noise stress,23
which is most harmful when emitted irregularly and unpre-
dictably.24 Thus, these sound frequencies may have induced
Figure 3 Hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity and
plasma glucose and insulin during an oral glucose tolerance test. (a) PEPCK
activity measured in microsomal extracts from the livers of three-month-old
vehicle (VEH)- and dexamethasone (DEX)-treated offspring. (b) Plasma
[glucose] and [insulin] quantified in blood taken at 09:00 from the tail-tip of
rats fasted overnight. Plasma glucose before, and at 30 and 120 min after
an oral glucose load, measured by hexokinase assay. (c) Plasma insulin
before, and at 30 and 120 min after an oral glucose load measured by enzyme-
linked immunosorbent assay. All data are presented as mean+SEM, n ¼ 7–8
per group
Figure 4 Offspring basal plasma corticosterone [CORT] concentrations.
Plasma [cort] quantified in blood taken from 08:00 from the tail-tip of male
and female offspring. Data are presented as mean+SEM, n ¼ 7–8 per group
................................................................................................................................................
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stress either pre- and/or postnatally to both VEH- and
DEX-treated cohorts through the maternal and/or fetal
HPA-axis and/or SNS.
Despite in utero growth retardation, the other well-
documented adult characteristics of the DEX-programmed
phenotype were nonexistent. As highlighted by Table 1,
this probably reﬂects alterations in the VEH-treated offspring
that developed a phenotype analogous to that of
DEX-offspring, without any appreciable modiﬁcation in the
phenotype of the latter. Given the null effect of perinatal
stress on the phenotype of the DEX-treated offspring, it is
tempting to speculate that there is an ‘upper limit’ for the
effects of prenatal glucocorticoids. Whether this ‘upper
limit’ is a result of modiﬁed GR and/or MR expression, or
is a function of enhanced glucocorticoid metabolism,
remains to be established. Alternatively, it is conceivable
that a factor exists, which antagonizes the effects of glucocor-
ticoids, thereby limiting their adverse effects in the long term.
Birth weights of both cohorts, but especially of
VEH-treated offspring, were signiﬁcantly reduced when
compared with previous25,26 and later15,22 studies, implying
that the initiation of environmental stress occurred before
birth. Subsequent catch-up growth of DEX-treated offspring
also failed to achieve completeness, and they remained on
average 11% lighter throughout adulthood, when compared
with controls, though the implications of this are controver-
sial. While complete26,27 and lack of catch-up growth28,29
have been demonstrated in several programming models,
each reported cohort still developed a ‘programmed’ pheno-
type. These studies support the present view that birth
weight and, therefore, subsequent catch-up growth form
relatively crude markers of exposure to an adverse intrau-
terine environment, rather than underlying a speciﬁc
cause of pathophysiology in the offspring. In a previous
study,22 birth weight and postnatal catch-up growth were
observed in both male and female DEX-treated offspring,
yet the adult ‘programmed’ phenotypes differed substan-
tially, consistent with this hypothesis.
At two and three months of age, no differences in systolic
blood pressure were detected by either tail-cuff plethysmo-
graphy or carotid cannulation. This contrasts with previous
reports that utilized these techniques to demonstrate hyper-
tension in DEX-treated adult offspring.22,25,30,31 While there
was an increase in systolic blood pressure between the time
of measurement at two and three months of age, it occurred
to the same degree in the offspring of both cohorts, and
possibly reﬂects perinatal stress programming.22,25,30–32
Interestingly, it is the VEH-treated offspring that demon-
strate blood pressure values equivalent to those normally
associated with prenatal DEX-programming,22,25,31 while
the DEX-treated offspring display typically expected
values, again suggesting that perinatal noise stress did not
add to their phenotype. In terms of mechanism for the
hypertension associated with perinatal stress programming,
it is most likely mediated through elevated glucocorti-
coids,25 altered sympathetic nerve responsivity15 and/or
an activated renin–angiotensinogen system.15,22,32,33
Furthermore, while tail-cuff plethysmography and carotid
cannulation are associated with considerable stress artefacts,
Figure 5 Corticosterone levels in vehicle (VEH)-treated male offspring and
naı¨ve males. Plasma [CORT] quantified in the blood taken from 08:00, from
the tail-tip of VEH-treated offspring aged eight months. Shown also are the
previous mean [CORT] for these rats when they were three months of age,
the upper limit of normal basal [CORT] (represented by a solid black line),
and the mean [CORT] measured in naı¨ve males aged three months. Data
are presented as mean+SEM, n ¼ 8 per group
Table 1 Comparison of prenatally treated offspring phenotypes before, during and after exposure to perinatal environmental stress
Parameter
Prenatal
treatment
Building construction
Before20,25 During After22
Birth weight (g) VEH 6.63+0.07 5.9+0.05 6.37+0.06
DEX 5.89+0.15 5.4+0.05 5.62+0.07
11% difference 8.5% difference 12% difference
Basal plasma [CORT] (nmol/L) VEH 79+15 286+96 53+14
DEX 115+29 216+131 139+32
Systolic BP (mmHg) VEH 133+2.7 141+6 133+3
DEX 144+2 144+5 147+3
Basal plasma glucose (mmol/L) VEH 4.3+0.2 5.67+0.2
DEX 5.3+0.3 5.72+0.4
Peak glucose in OGTT (mmol/L) VEH 7.5+0.2 10.4+0.9 9.3+0.2
DEX 8.7+0.4 10.7+0.4 10.6+0.5
Peak insulin in OGTT (ng/mL) VEH 3.8+0.5 10.7+0.8 4.21+0.7
DEX 6.1+0.5 8.8+1.2 8.28+1.4
Hepatic PEPCK activity DEX Increased by 60% Increased by 3% Increased by 40%
Measurements of birth weight, basal corticosterone levels, systolic blood pressure†, hepatic PEPCK activity, and plasma glucose† and insulin in male offspring of
VEH- and DEX-treated dams are shown before, during and after nearby construction work. Data are mean+SEM; all analyses utilize Student’s t-test and compare
VEH versus DEX during a specific time period, P, 0.05
Note: †The systolic blood pressure measurements cited after nearby building construction are from female offspring. The plasma glucose level results are courtesy
of Dr ME Cleasby (personal communication)
VEH: vehicle; DEX: dexamethasone; BP: blood pressure; OGTT: oral glucose tolerance test; PEPCK: phosphoenolpyruvate carboxykinase
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the nature of their varying effects on both VEH- and
DEX-treated offspring does not implicate them as causative
factors in the hypertension detected here.15
In further contrast to previous19,26 and subsequent22,34
ﬁndings, prenatal DEX treatment did not affect plasma
glucose or insulin levels measured at three time points
during an OGTT. However, increases in both these plasma
variables following the oral glucose load indicate that
nothing went awry with the procedure.20 In line with
birth weight and blood pressure data from the present
cohorts, the elevated plasma glucose and insulin concen-
trations measured in VEH-treated offspring mirrored those
typically expected of prenatal DEX-treated offspring.
Furthermore, the comparable insulin–glucose proﬁle of
these offspring cohorts is consistent with their identical
hepatic PEPCK activities. Such elevated levels of activity
are normally associated with the hyperglycaemia found
exclusively in prenatal DEX-treated offspring.22,26
Highly elevated levels of plasma corticosterone, indicative
of stress, were observed in both cohort offspring, and again,
unlike previous13,25 and later15,22 ﬁndings, no differences
between cohorts were detected. During construction, rat
corticosterone levels were assayed at regular intervals,
serving as environmental stress monitors. These rats,
though born in the animal facility, were not subjected to
any in utero manipulation. However, they too repeatedly
displayed equivalent levels of corticosterone, suggesting
that perinatal stress had programmed the HPA axis of
each animal born within the facility, which could be
further acted upon by construction disturbances. Indeed,
following the cessation of building works, plasma corticos-
terone values fell dramatically, but still remained in excess
of the upper normal basal limit, revealing continued lifelong
HPA dysfunction. At this time naı¨ve adult males were intro-
duced to the animal facility, and displayed appropriate
basal plasma corticosterone levels, suggesting that exposure
to the stressors during the perinatal period is critical to
programming later dysfunction.
In conclusion, it is evident that perinatal stress induced
by environmental disturbance is sufﬁcient to confound
prenatal DEX-programming experiments. This perinatal
stress successfully introduced low birth weight, hypercorti-
costeronaemia, insulin resistance and hypertension to
VEH-treated offspring, such that the typical distinctions
between both treatment groups were completely amelio-
rated. The lack of an additional effect on DEX-treated off-
spring is suggestive of an ‘upper limit’ effect of prenatal
stress or glucocorticoids, serving to prevent against the
potentially detrimental effects of sustained glucocorticoid
hyper-exposure. Finally, perinatal stress is further able to
programme HPA-axis dysfunction in offspring that were
not additionally subjected to any other in utero
manipulations.
With the demonstrated ability to modify complex physio-
logical systems, it is quite conceivable that construction
work may serve as a major contributor to the reports of ‘bio-
logical variability’. As our other studies have illustrated,15,22
under well-controlled conditions, biological variability is
actually quite negligible, and those environmental variables,
which may go unnoticed by many researchers (particularly
those that utilize animal tissues harvested by others), can
cause pronounced, misleading, and costly alterations in
otherwise robust model systems.
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